| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101492053-B1 |
| titleOfInvention |
Composition comprising Neuropeptide Y for Anti chemotherapy side effect |
| abstract |
The present invention provides a composition for inhibiting the side effects of anticancer drugs comprising neuropeptide Y. The neuropeptide Y of the present invention exerts an effect of alleviating the side effects exerted by the administration of the anticancer agent, particularly bone marrow injury and neuropathy, and is useful as an anti-cancer adjuvant which can alleviate side effects of the anticancer agent and increase the anticancer agent effect have. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170101124-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101923660-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101890798-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101826208-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019009582-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017146528-A1 |
| priorityDate |
2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |